Fidelity Investments
AVBP icon

Fidelity Investments’s ArriVent BioPharma AVBP Stock Holding History

Fidelity Investments’s Portfolio AVBP Stock Details AVBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$96.5M Sell
2,778,959
-237,173
-8% -$7M ﹤0.01% 1240
2026
Q1 		$69.6M Sell
3,016,132
-687,440
-19% -$15.5M ﹤0.01% 1315
2025
Q4 		$74.5M Buy
3,703,572
+296,023
+9% +$6.16M ﹤0.01% 1291
2025
Q3 		$62.9M Buy
3,407,549
+1,349,480
+66% +$26.5M ﹤0.01% 1360
2025
Q2 		$44.8M Sell
2,058,069
-20,590
-1% -$428K ﹤0.01% 1440
2025
Q1 		$38.4M Sell
2,078,659
-22,378
-1% -$548K ﹤0.01% 1453
2024
Q4 		$56M Sell
2,101,037
-18,658
-0.9% -$536K ﹤0.01% 1340
2024
Q3 		$49.8M Buy
2,119,695
+169,514
+9% +$3.85M ﹤0.01% 1373
2024
Q2 		$36.2M Buy
1,950,181
+147
+0% +$2.62K ﹤0.01% 1436
2024
Q1 		$34.8M Buy
+1,950,034
New +$39.3M ﹤0.01% 1466

Other funds holding AVBP

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Fidelity Investments's AVBP Position: Q2 2026 in Review

Fidelity Investments reduced its ArriVent BioPharma (AVBP) stake by 7.9% in Q2 2026, selling an estimated $7M and leaving 2,778,959 shares worth $96.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1240.

Fidelity Investments first reported a position in AVBP in Q1 2024 and has held it in 10 quarters since. 157 funds tracked by Wall St. Rank hold AVBP as of Q2 2026.

  • Fidelity Investments held 2,778,959 shares of ArriVent BioPharma worth $96.5M as of Q2 2026.
  • Fidelity Investments sold 237,173 ArriVent BioPharma shares in Q2 2026, an estimated $7M.
  • ArriVent BioPharma made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #1240 holding.
  • Fidelity Investments first reported a position in ArriVent BioPharma in Q1 2024 and has held it in 10 quarters since.
  • 157 funds tracked by Wall St. Rank held ArriVent BioPharma as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.